
Sue S. Yom MD PhD
Head & Neck, Skin Cancer, Thoracic Cancer
Professor, Radiation Oncology, UCSF School of Medicine
Join to View Full Profile
1825 4th StreetSuite L1101San Francisco, CA 94143
Phone+1 415-353-7175
Fax+1 415-353-9883
Dr. Yom is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Sue Yom, MD, based in San Francisco, CA, is a specialist in Radiation Oncology with subspecialties in head and neck, skin cancer, and thoracic cancer. She completed her medical education at the Perelman School of Medicine at the University of Pennsylvania, followed by an internship in Internal Medicine at the University of Texas Health Science Center at Houston, and a residency in Radiation Oncology at the University of Texas MD Anderson Cancer Center. Dr. Yom's publications focus on treatment outcomes, quality of life, and translational research for head and neck, skin, and lung cancer patients. Dr. Yom has been involved in multiple clinical trials investigating treatments for various cancers, including oropharyngeal and nasopharyngeal carcinoma, non-small cell lung cancer, and advanced basal cell carcinoma. She has received the Most Compassionate Doctor award from the American Registry. She has been named as a Castle Connolly Top Doctor since 2023.
Education & Training
University of Texas M D Anderson Cancer CenterResidency, Radiation Oncology, 2003 - 2007
University of Texas Health Science Center at HoustonInternship, Internal Medicine, 2002 - 2003
Perelman School of Medicine at the University of PennsylvaniaClass of 2002
Certifications & Licensure
CA State Medical License 2007 - 2026
TX State Medical License 2007 - 2025
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- Most Compassionate Doctor American Registry
Clinical Trials
- TRYHARD: Radiation Therapy Plus Cisplatin With or Without Lapatinib in Treating Patients With Head and Neck Cancer. Start of enrollment: 2013 Mar 15
- Phase II Study of Radiation Therapy and Vismodegib for Advanced Head/Neck Basal Cell Carcinoma Start of enrollment: 2013 May 01
- Study of Personalized Sterile Humidification Device for Mucositis in Head and Neck Cancer Patients Start of enrollment: 2013 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- Long-Term Feeding Tube Use in Head and Neck Cancer Survivors-An Analysis of Patient- and Treatment-Related Factors.Thomas J Galloway, Stephanie L Pugh, John A Ridge, Phuc Felix Nguyen-Tan, David I Rosenthal
International Journal of Radiation Oncology, Biology, Physics. 2025-11-01 - 1 citationsAddressing Clinical Challenges of Reirradiation: A Continuum of Evolving Options.Lawrence B Marks, Nicolaus Andratschke, Sue S Yom, Kelly C Paradis, Charles S Mayo
International Journal of Radiation Oncology, Biology, Physics. 2025-11-01 - Circulating tumor DNA level is associated with time to clinical recurrence in Merkel cell carcinoma: Implications for patient management.Tomoko Akaike, Manisha Thakuria, Ann W Silk, Daniel S Hippe, Peter Y Ch'en
Journal of the American Academy of Dermatology. 2025-10-10
Press Mentions
Cancer Stole Her Voice. AI, Curse Words and Children's Books Saved ItJuly 22nd, 2025
NRG Oncology Names New Chairs for Patient Advocate and Head & Neck Cancer CommitteesJune 26th, 2025
NRG Oncology Appoints New Leaders to Patient Advocate Committee and Head and Neck Cancer CommitteeJune 26th, 2025- Join now to see all
Grant Support
- Oral microbiome and inflammatory status in antimicrobially-treated oral cancer patientsUNIVERSITY OF CALIFORNIA LOS ANGELES2022–2027
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









